Bayesian Capital Management, LP Guardant Health, Inc. Transaction History

Bayesian Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $440,231 - $601,800	-20,400 Reduced 52.71%	18,300 $495,000
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $998,460 - $1.55 Million	38,700 New	38,700 $1.15 Million
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $750,634 - $1.13 Million	-12,714 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $1.08 Million - $1.5 Million	-18,100 Reduced 58.74%	12,714 $993,000
Q3 2019 Nov 13, 2019	BUY	$62.59 - $110.3 $1.35 Million - $2.38 Million	21,597 Added 234.32%	30,814 $1.97 Million
Q2 2019 Aug 13, 2019	BUY	$63.94 - $91.11 $377,949 - $538,551	5,911 Added 178.8%	9,217 $796,000
Q1 2019 May 14, 2019	BUY	$34.3 - $97.98 $113,395 - $323,921	3,306 New	3,306 $254,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.